Last reviewed · How we verify

NCT03625492: FABULUS

Fluids Affecting Bladder Urgency and Lower Urinary Symptoms

Completed NA Last updated 14 November 2019
What this trial tests

NA trial testing Reducing Potentially Irritating Beverages in Overactive Bladder in 65 participants. Completed in 17 September 2019.

Timeline
7 August 2018
Primary endpoint
17 September 2019
17 September 2019

Quick facts

Lead sponsorUniversity of Michigan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment65
Start date7 August 2018
Primary completion17 September 2019
Estimated completion17 September 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Michigan

Who can join

18 and older, female only, with Overactive Bladder or Urinary Urgency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates whether eliminating certain ingredients (caffeine, alcohol, artificial sweeteners, acidic juices) consumed in beverages reduces bladder symptoms of urinary frequency and urgency. Women with overactive bladder will be recruited. Half of these women will receive instructions to replace beverages containing these ingredients with beverages such as water or milk. The other half of participants will receive instructions on following the United States Department of Agriculture guidelines on healthy eating.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Overactive Bladder

Currently open trials in the same condition.

Other University of Michigan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03625492.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing